Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France  B. Amadeo, C. Dumartin,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study  J. Gonçalves-Pereira,
Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France  D.
L. Boyanova  Clinical Microbiology and Infection 
Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre  J.M. Cisneros, O. Neth, M.V.
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis  J.
Herpes zoster in non-hospitalized children
An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia  A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford,
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.
Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis*  B.J. Holzknecht, J. Thorup, M.C. Arendrup, S.E.
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A guide to interpreting economic studies in infectious diseases
Dynamics of serum procalcitonin in patients after major neurosurgery
Adult bacterial meningitis—a quality registry study: earlier treatment and favourable outcome if initial management by infectious diseases physicians 
R. Cantón  Clinical Microbiology and Infection 
A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J
Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations  R. Ashley-Morrow,
Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals 
M. Maurin, L. Hammer, B. Gestin, J. F. Timsit, O. Rogeaux, F
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic  A.S.
Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland  E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.
Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia  M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,
Clinical Microbiology and Infection
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study  J. Gonçalves-Pereira,
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests  R. Achermann, K. Suter, A. Kronenberg,
B. Huttner, S. Harbarth, D. Nathwani 
B. Gordts  Clinical Microbiology and Infection 
A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro 
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community  R.E. Warren, G. Harvey, R. Carr, D. Ward,
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
C.G. Teo  Clinical Microbiology and Infection 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals  H. von.
Recent developments in staphylococcal scalded skin syndrome
J. Garau  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during.
Antibacterial drug discovery in the 21st century
N. Jazmati, M. Hellmich, B. Ličanin, G. Plum, A.J. Kaasch 
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.
Reducing antibiotic use in influenza: challenges and rewards
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre  J.M. Cisneros, O. Neth, M.V.
W. Eugene Sanders, Christine C. Sanders 
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis  Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia  U. Hohenthal, S. Hurme, H. Helenius,
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study 
Serum ferritin levels in West Nile encephalitis
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
The future of diagnostic bacteriology
Presentation transcript:

Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France  B. Amadeo, C. Dumartin, P. Robinson, A.G. Venier, P. Parneix, J.P. Gachie, A. Fourrier-Réglat, A.M. Rogues  Clinical Microbiology and Infection  Volume 16, Issue 6, Pages 735-741 (June 2010) DOI: 10.1111/j.1469-0691.2009.02920.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Distribution of total antibiotic consumption in public and private hospitals, expressed as defined daily doses (DDD)/1000 patient-days and 100 admissions. The box stretches from the lower hinge (the 25th percentile) to the upper hinge (the 75th percentile). The median is shown as a line across the box. Therefore, a quarter of the distribution is between this line and the top of the box. The line above the upper hinge is the 90th percentile and the line below the lower hinge is the 10th percentile. Filled circles represent hospitals which have a total consumption superior at the 90th percentile or inferior at the 10th percentile. Clinical Microbiology and Infection 2010 16, 735-741DOI: (10.1111/j.1469-0691.2009.02920.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Multivariate model of antibiotic consumption in the public hospitals (actual vs. predicted). The model used to calculate the predicted consumption was as follows: predicted antibacterial consumption expressed as defined daily doses (DDD)/1000 patient-days (PDs) = 135.3 + 28.3 (proportion of PDs in intensive care) + 5.1 (proportion of PDs in surgery) + 4.7 (proportion of PDs in medical ward) + 18.6 (existence of infectious diseases consultant). Filled circles represent hospitals. The horizontal line indicates the median value of actual antibiotic consumption. The continuous line and the two discontinuous lines represent the predicted antibiotic consumption and 90% prediction intervals, respectively. Clinical Microbiology and Infection 2010 16, 735-741DOI: (10.1111/j.1469-0691.2009.02920.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Multivariate model of antibiotic consumption in the public hospitals (actual vs. predicted). The model used to calculate the predicted consumption was as follows: predicted antibiotic consumption expressed in defined daily doses (DDD)/100 admissions = −200.6 + 55.0 (length of stay (days)) + 1.7 (proportion of patient-days (PDs) in surgery) + 1.6 (proportion of PDs in medical ward) + 18.6 (existence of infectious diseases consultant). Filled circles represent hospitals. The horizontal line indicates the median value of actual antibiotic consumption. The continuous line and the two discontinuous lines represent the predicted antibiotic consumption and 90% prediction intervals, respectively. Clinical Microbiology and Infection 2010 16, 735-741DOI: (10.1111/j.1469-0691.2009.02920.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions